Copying Ekta Bagri's trades since 2018 and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -1.7% per rating.

Stock Rating Distribution

100.00% Bullish

0.00% Neutral

0.00% Bearish

Distribution of Ekta Bagri's ratings

Additional Information

Main Sector:General

Geo Coverage:

US Market

Best Rating

Stock:

Sarepta Therapeutics Inc.
(SRPT)

Rating:Buy

Date:Jan 05, 2024 - Today

Return:+32.20%

The most profitable rating made by Ekta Bagri

Ekta Bagri's Stock Coverage

CELG

Celgene

Aug 23, 2018

Bullish

1Ratings

+4.60%

VRTX

Vertex Pharmaceuticals

Aug 23, 2018

Bullish

1Ratings

+2.30%

ALXN

Alexion Pharmaceuticals

Dec 11, 2018

Bullish

1Ratings

-4.60%

BIIB

Biogen

Dec 11, 2018

Bullish

1Ratings

-8.60%

GILD

Gilead Sciences

Dec 11, 2018

Bullish

2Ratings

-3.95%

NVS

Novartis

Jul 29, 2021

Bullish

1Ratings

-4.40%

REGN

Regeneron

Jan 05, 2024

Bullish

3Ratings

-9.33%

SRPT

Sarepta Therapeutics

Jan 05, 2024

Bullish

1Ratings

+32.20%

BGNE

BeiGene

Jan 05, 2024

Bullish

1Ratings

-7.10%

List of latest recommendations made by Ekta Bagri. Click to expand and see Ekta Bagri's performance on a particular stock

Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site.

Ekta Bagri Profile - Zacks Equity Research Blogger

Ekta Bagri Zacks Equity Research

Success Rate

Average Return

Stock Rating Distribution

Additional Information

Best Rating

Ekta Bagri's Stock Coverage

Ekta Bagri
Zacks Equity Research